Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Section of Dermatology, Department of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Pediatr Dermatol. 2022 May;39(3):491-493. doi: 10.1111/pde.14949. Epub 2022 Mar 1.
We report the case of a 2-year-old boy with mosaic trisomy 13 and immunodeficiency who developed severe hidradenitis suppurativa beginning at the age of 18 months. Unresponsive to standard therapies, he exhibited a partial response to immunoglobulin replacement therapy.
我们报告了一例 2 岁患有嵌合体 13 三体和免疫缺陷的男孩,他在 18 个月大时开始患有严重的化脓性汗腺炎。尽管接受了标准治疗,但他没有反应,而免疫球蛋白替代疗法显示出部分反应。